Generics - Mylan Laboratories, Actavis

Filter

Current filters:

Mylan LaboratoriesActavis

Popular Filters

Generics briefs: Actavis/Warner Chilcott M&A delay; Canasa patent challenge

11-07-2013

US generics major Actavis (NYSE: ACT) and Ireland-based Warner Chilcott (Nasdaq: WCRX) have each received…

ActavisAptalis PharmaCanasaGenericsLegalMergers & AcquisitionsMylan LaboratoriesNorth AmericaPatentsWarner Chilcott

EU Commission fines Lundbeck and other Pharmas over "pay-for-delay" deals

19-06-2013

In a much awaited decision following its investigations of patent settlements (or pay-for-delay deals)…

ActaviscitalopramEuropeFinancialGenericsLegalLundbeckMerck KGaAMylan LaboratoriesNeurologicalPatentsPharmaceuticalRanbaxy Laboratories

Actavis and Valeant to co-promote Zovirax and Cordran Tape

07-04-2013

Valeant Pharmaceuticals International (TSX: VRX) entered into an agreement, effective immediately, for…

ActavisAnti-viralsCordran TapeGenericsLicensingMarkets & MarketingMylan LaboratoriesNorth AmericaValeant PharmaceuticalsZovirax Ointment

Mylan extends deal with Bioton to biosimilar insulins, as Actavis pulls out of JV

14-02-2013

US generic drugmaker Mylan (Nasdaq: MYL) said yesterday that it has entered into a definitive agreement…

ActavisBiotechnologyBiotonDiabetesEli LillyGenericsHumalogLantusLicensingMarkets & MarketingMylan LaboratoriesNovo NordiskNovoLogSanofi

Endo fails in FDA law suit to stop generic Opana ER in USA; Mylan settles with Orion

21-12-2012

The US District Judge Reggie Walton, of the District Court for the District of Columbia, has dismissed…

ActavisComtanEndo PharmaceuticalsGenericsImpax LaboratoriesLegalMylan LaboratoriesNeurologicalNorth AmericaOpana ERPharmaceutical

Roche ups bid for Illumina; M&A speculation on Amylin, Actavis

29-03-2012

There was a plethora of merger and acquisition news coming out yesterday and this morning, first of which…

ActavisAmylinBiotechnologyBristol-Myers SquibbGenericsIlluminaMergers & AcquisitionsMylan LaboratoriesPharmaceuticalRocheWatson Pharmaceuticals

FDA OKs generic Ritalin for Actavis and Mylan’s Keppra

04-01-2012

Iceland-based generic drugmaker Actavis says that it recently received approval from the US Food and…

ActavisGenericsKeppra XRMylan LaboratoriesNeurologicalRegulationRitalin LA

Back to top